Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) have been given an average recommendation of “Buy” by the twelve ratings firms that are presently covering the company, Marketbeat reports. Ten equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have covered the stock in the last year is $44.58.

A number of brokerages recently issued reports on PRVA. Canaccord Genuity Group upped their target price on Privia Health Group from $45.00 to $50.00 and gave the company a “buy” rating in a research report on Thursday, August 25th. Cowen upped their target price on Privia Health Group from $35.00 to $44.00 and gave the company an “outperform” rating in a research report on Friday, August 12th. Canaccord Genuity Group increased their price objective on Privia Health Group from $45.00 to $50.00 in a research report on Thursday, August 25th. BTIG Research increased their price objective on Privia Health Group to $45.00 in a research report on Monday, August 15th. Finally, Guggenheim increased their price objective on Privia Health Group from $36.00 to $51.00 and gave the stock a “buy” rating in a research report on Friday, August 12th.

Privia Health Group Stock Down 2.2 %

Shares of NASDAQ PRVA opened at $41.27 on Friday. The stock has a market cap of $4.59 billion, a PE ratio of -89.72 and a beta of 1.06. Privia Health Group has a 52-week low of $17.99 and a 52-week high of $44.64. The business has a 50-day moving average price of $36.94 and a 200 day moving average price of $29.34.

Insider Transactions at Privia Health Group

In other news, COO Parth Mehrotra sold 60,000 shares of the stock in a transaction that occurred on Tuesday, June 21st. The stock was sold at an average price of $29.22, for a total transaction of $1,753,200.00. Following the completion of the transaction, the chief operating officer now directly owns 97,391 shares of the company’s stock, valued at approximately $2,845,765.02. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, COO Parth Mehrotra sold 60,000 shares of the stock in a transaction that occurred on Tuesday, June 21st. The stock was sold at an average price of $29.22, for a total transaction of $1,753,200.00. Following the completion of the transaction, the chief operating officer now directly owns 97,391 shares of the company’s stock, valued at approximately $2,845,765.02. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Thomas Bartrum sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 21st. The shares were sold at an average price of $29.24, for a total value of $292,400.00. Following the completion of the transaction, the executive vice president now directly owns 91,355 shares of the company’s stock, valued at $2,671,220.20. The disclosure for this sale can be found here. In the last three months, insiders sold 662,023 shares of company stock valued at $22,218,916. Corporate insiders own 57.60% of the company’s stock.

Hedge Funds Weigh In On Privia Health Group

Hedge funds have recently bought and sold shares of the company. Assetmark Inc. increased its stake in Privia Health Group by 119.4% in the 2nd quarter. Assetmark Inc. now owns 893 shares of the company’s stock valued at $26,000 after purchasing an additional 486 shares in the last quarter. Rockefeller Capital Management L.P. purchased a new position in Privia Health Group in the 4th quarter valued at approximately $25,000. First Horizon Advisors Inc. purchased a new position in Privia Health Group in the 4th quarter valued at approximately $26,000. Nisa Investment Advisors LLC purchased a new position in Privia Health Group during the second quarter worth $46,000. Finally, Point72 Hong Kong Ltd purchased a new position in Privia Health Group during the first quarter worth $47,000. 62.81% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Stories

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.